Evaluating the Impact of COVID-19 (Coronavirus) on Research in Care Homes
NCT ID: NCT04716972
Last Updated: 2022-11-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
7 participants
OBSERVATIONAL
2021-04-14
2022-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Nevertheless, as care home residents are a vulnerable group, it is critical to include these groups in research in order to enable improved and evidence-based care and their access to new and emerging treatments.
This study aims to assess the opinions and experiences of key stakeholders to identify barriers, and enable better facilitation of research in these settings during and post pandemic.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patients' Experiences in a Medicalized Hotel for COVID-19 Acute Care Support
NCT04503434
Factors Affecting Mortality in Covid-19 Disease
NCT06043115
How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?
NCT04348227
Home-based Care and Hand Hygiene Interventions in Honduras
NCT04886414
Shaping Care Home COVID-19 Testing Policy
NCT05639205
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Phase one will involve mixed methods surveys. One will be completed by care home residents and the other will be completed by research delivery staff and care home staff.
Phase two will involve qualitative interviews with each of these groups to enable better insight into their views and opinions on research in this area.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Online Survey
Online survey
survey
Online survey
Interviews
Interviews
Interview
Interview
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
survey
Online survey
Interview
Interview
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Any relative/friend of a care home resident in the West Midlands
* Any staff member or volunteer working in care home in the West Midlands
* Any researcher undertaking research in a care home in the West Midlands (during the pandemic or proposed during the pandemic period)
Exclusion Criteria
* Individuals who lack capacity
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Royal Wolverhampton Hospitals NHS Trust
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kelly Hard
Role: PRINCIPAL_INVESTIGATOR
National Institute for Health Research, United Kingdom
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Royal Wolverhampton NHS Trust
Wolverhampton, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021COV114
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.